Take a look at our previous reports:

At a glance

Consolidated Key Figures

(thousands of €, if not stated otherwise)

Year ended
31 December 2021

Year ended
31 December 2020

Year ended
31 December 2019

Income statement(*)

 

 

 

Product net sales

14,753

2

-

Collaboration revenues

470,093

478,051

834,901

Cost of sales

(1,629)

-

-

R&D expenditure

(491,707)

(523,667)

(420,090)

S, G&A expenses

(210,855)

(185,225)

(96,959)

Other operating income

53,749

52,207

50,896

Operating profit/loss (-)

(165,596)

(178,632)

368,748

Net financial results

42,598

(131,143)

(220,223)

Taxes

(2,423)

(1,226)

165

Net profit/loss (-) from continuing operations

(125,422)

(311,001)

148,689

Net profit from discontinued operations, net of tax

22,191

5,565

1,156

Net profit/loss (-)

(103,231)

(305,436)

149,845

 

 

 

 

Balance sheet

 

 

 

Cash and cash equivalents

2,233,368

2,135,187

1,861,616

Current financial investments

2,469,809

3,026,278

3,919,216

R&D incentives receivables

144,013

135,728

115,356

Assets

5,193,160

5,717,731

6,068,609

Shareholders' equity

2,643,362

2,670,355

2,875,658

Deferred income

2,364,701

2,809,133

3,000,646

Other liabilities

185,097

238,242

192,305

 

 

 

 

Cash flow

 

 

 

Operational cash flow/operational cash burn (-)(**)

(564,840)

(517,404)

3,162,809

Cash flow generated from/used in (-) operating activities

(503,827)

(427,336)

3,208,617

Cash flow generated from/used in (-) investing activities

541,238

757,288

(3,764,660)

Cash flow generated from/used in (-) financing activities

(3,876)

22,040

1,335,751

Increase in cash and cash equivalents

33,535

351,994

779,708

Transfer to current financial investments

-

-

(198,922)

Effect of currency exchange rate fluctuation on cash and cash equivalents

56,763

(70,539)

(9,966)

Cash and cash equivalents on 31 December

2,233,368

2,143,071

1,861,616

 

 

 

 

Cash and cash equivalents from continuing operations

2,233,368

2,135,187

1,861,616

Cash and cash equivalents classified as assets held for sale

-

7,884

-

Current financial investments on 31 December

2,469,809

3,026,278

3,919,216

Total current financial investments and cash and cash equivalents on 31 December

4,703,177

5,169,349

5,780,832

 

 

 

 

Financial ratios

 

 

 

Number of shares issued on 31 December

65,552,721

65,411,767

64,666,802

Basic income/loss (-) per share (in €)

(1.58)

(4.69)

2.60

Diluted income/loss (-) per share (in €)

(1.58)

(4.69)

2.49

Share price on 31 December (in €)

49.22

80.48

186.50

Total group employees on 31 December (number)(***)

1,309

1,489

1,003

(*)

The comparatives of 31 December 2019 have been restated to consider the impact of classifying the Fidelta business as discontinued operations in 2019.

(**)

We refer to note 20 of our consolidated financial statements for an explanation and reconciliation of this alternative liquidity measure.

(***)

The number of employees on 31 December 2020 and on 31 December 2019 included respectively 185 and 158 employees of Fidelta, which has been sold to Selvita on 4 January 2021.

Employees per site

Employees per site (graphic)

Number of employees Galapagos group

Number of employees Galapagos group  (graphic)
Total number of employees includes consultants and temporary staff